Baird Maintains an 'Outperform' on InterMune Inc. (ITMN); Incrementally Positive on Favorable Reimbursement Decision for Esbriet in Germany

Go back to Baird Maintains an 'Outperform' on InterMune Inc. (ITMN); Incrementally Positive on Favorable Reimbursement Decision for Esbriet in Germany